Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESY
3776
Cresud
CRESY
$773M
| $292K | ﹤0.01% |
34,112
| – | – |
|
3777
Precision Optics
POCI
$46.2M
| $292K | ﹤0.01% |
52,268
+25,530
| +95% | +$145K |
|
|
TBHC
3778
DELISTED
The Brand House Collective
TBHC
| $290K | ﹤0.01% |
132,445
+9,431
| +8% | +$15.8K |
|
3779
Dare Bioscience
DARE
$21M
| $289K | ﹤0.01% |
89,060
+5,180
| +6% | +$17.7K |
|
|
HYPD
3780
Hyperion DeFi Inc
HYPD
$40.9M
| $288K | ﹤0.01% |
6,975
+1,868
| +37% | +$120K |
|
3781
Envoy Medical
COCH
$51.7M
| $288K | ﹤0.01% |
88,544
+1,585
| +2% | +$4.31K |
|
3782
Rafael Holdings
RFL
$107M
| $287K | ﹤0.01% |
150,141
+29,860
| +25% | +$44.7K |
|
3783
Rallybio
RLYB
$85.8M
| $287K | ﹤0.01% |
30,623
+3,122
| +11% | +$30.1K |
|
|
ZJYL
3784
Jin Medical International
ZJYL
$16.8M
| $287K | ﹤0.01% |
5,327
| – | – |
|
3785
Intellinetics
INLX
| $285K | ﹤0.01% |
25,422
+6,563
| +35% | +$57.8K |
|
3786
Capital Southwest
CSWC
$1.6B
| $285K | ﹤0.01% |
11,251
| – | – |
|
3787
CareCloud
CCLD
$112M
| $284K | ﹤0.01% |
107,700
-6,653
| -6% | -$15.9K |
|
|
OMGA
3788
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $282K | ﹤0.01% |
230,833
-6,000
| -3% | -$9.55K |
|
|
OMIC
3789
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $282K | ﹤0.01% |
17,962
+1,193
| +7% | +$10.6K |
|
3790
NeuroOne Medical Technologies
NMTC
$14.2M
| $281K | ﹤0.01% |
47,309
+4,162
| +10% | +$20.8K |
|
3791
Where Food Comes From
WFCF
$64.7M
| $280K | ﹤0.01% |
25,955
+4,984
| +24% | +$54.7K |
|
3792
Vinci Compass Investments Ltd
VINP
$660M
| $279K | ﹤0.01% |
28,108
+814
| +3% | +$8.67K |
|
3793
MultiSensor AI
MSAI
$10.7M
| $279K | ﹤0.01% |
3,230
+1,938
| +150% | +$145K |
|
|
LAC
3794
Lithium Americas
LAC
$1.17B
| $279K | ﹤0.01% |
103,275
+18,321
| +22% | +$46.5K |
|
3795
Acurx Pharmaceuticals
ACXP
$6.62M
| $278K | ﹤0.01% |
7,325
+824
| +13% | +$34.9K |
|
3796
Corvex Inc
MOVE
$358M
| $275K | ﹤0.01% |
6,941
+1,262
| +22% | +$48.8K |
|
|
PBBK
3797
DELISTED
PB Bankshares
PBBK
| $274K | ﹤0.01% |
17,709
+2,836
| +19% | +$43.9K |
|
3798
SurgePays
SURG
$7.27M
| $272K | ﹤0.01% |
148,018
+15,039
| +11% | +$34.1K |
|
3799
Lulu's Fashion Lounge
LVLU
$52.3M
| $272K | ﹤0.01% |
11,338
+680
| +6% | +$15.2K |
|
3800
Exagen
XGN
$166M
| $271K | ﹤0.01% |
87,615
| – | – |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.